Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-02-06
1977-11-29
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260256, A61K 3152, C07D47308
Patent
active
040606180
ABSTRACT:
There are prepared quaternary xanthinylalkylnortropine derivatives of the general formula I ##STR1## where T represents a theophyllinyl-7 radical or a theobrominyl-(1)-radical, Alk is a straight or branched chain alkylene group having 2 to 10 carbon atoms or such a group substituted by a hydroxyl group, R is an alkyl group of 1 to 4 carbon atoms and A.sup.(-) is an equivalent to an anion of a physiologically compatible mono- or polyvalent acid. The compounds are useful as medicines having a spasmolytic activity.
REFERENCES:
patent: 3472861 (1969-10-01), Zeile et al.
patent: 3505337 (1970-04-01), Zeile et al.
Aurich Rudolf
Habersang Silke
Klingler Karl H.
Coughlan, Jr. Paul M.
Deutsche Gold- und Silber-Scheideanstalt vormals Roessler
LandOfFree
Quaternary xanthinylalkyl nortropine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quaternary xanthinylalkyl nortropine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quaternary xanthinylalkyl nortropine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1633832